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Abstract To assess the accuracy of a single channel
portable monitoring device (RUSleeping™ RTS, Respir-
onics, Murrysville, PA) that measures nasal pressure (a
surrogate for airflow) to detect sleep disordered breathing
(SDB). Twenty-five adult patients referred to a community
sleep laboratory with suspected obstructive sleep apnea
(OSA) participated in this investigation. The portable
monitoring device was used in the sleep laboratory to
acquire data concurrently with a standard multi-channel
polysomnogram (PSG) to assess SDB. Respiratory events
were scored manually on the PSG using standard criteria
for clinical research to quantify an apnea–hypopnea index
(AHI) based on events during sleep. The portable monitor-
ing device automatically calculated an unedited respiratory
event index (REI) based on recording time. These data were
then compared using the Pearson product–moment correla-
tion coefficient, Bland–Altman analysis, receiver operating
characteristic (ROC) curves, and likelihood ratios. All 25
subjects completed the study. Mean age of subjects was
42.4±12.9 years and mean body mass index was 31.0±
7.4 kg m−2. There was good agreement between the REI
and the AHI (R=0.77, p<0.001, mean difference 2.6 events
per hour [2 SD: 39.8] using a Bland–Altman plot). The area
under the ROC curve for detecting SDB (PSG AHI greater
than or equal to five events per hour) with the REI was 0.94
(95% CI 0.84–1.0). For an REI >11.9 events per hour, the
sensitivity was 0.89 (95% CI 0.65–0.99) and the specificity
was 0.86 (95% CI 0.42–1.0) with a likelihood ratio of 6.2
for a positive test (LR+) and 0.13 for a negative test (LR−).
Similar results were observed for detecting moderate–
severe SDB (PSG AHI≥15 events h−1) using REI >15.2
events h−1. In a population of subjects with suspected OSA,
this portable monitoring device can automatically quantify
an REI that compares well to the AHI scored manually on a
concurrent PSG. Such a device may prove useful to assess
SDB in high risk populations with self-administered testing
in ambulatory settings such as the home.
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Introduction
Sleep-disordered breathing (SDB) is a common disorder
with important clinical consequences for affected individ-
uals. Obstructive sleep apnea (OSA), a common form of
SDB, is highly prevalent in adults with approximately one
in five adults having at least mild OSA and one in 15 adults
having OSA with moderate severity or worse [1]. OSA is
characterized by repetitive collapse of the pharyngeal
airway during sleep, yielding hypoxia, hypercapnia, and
arousal from sleep to reestablish airway patency [2]. The
associated consequences include daytime sleepiness [3],
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decreased cognitive performance, decreased quality of life
[4], increased risk of automobile and industrial accidents [5,
6], and adverse cardiovascular sequelae [7–10]. Treatment
of OSA leads to improvements in many of these adverse
outcomes and may reduce healthcare costs [11–13]. Thus,
diagnosis of this disorder is important.
Referral to a sleep laboratory for overnight polysomnog-
raphy (PSG) is the most common diagnostic pathway for
patients with suspected sleep apnea. This procedure includes
continuous recordings of many physiologic data including
airflow, chest/abdominal excursion, electroencephalography,
electro-oculography, electromyography, electrocardiogra-
phy, and oxyhemoglobin saturation [14]. Apneas and
hypopneas are detected with the monitoring equipment
during periods of sleep to generate an apnea–hypopnea
index (AHI) representing the number of these events per
hour of sleep. However, PSG in the sleep laboratory is
expensive, cumbersome, and not readily available in many
geographic areas due to a growing demand for the
procedure [15].
Assessing SDB with a portable monitoring device based
on a limited number of channels in an ambulatory setting
such as the home could improve access to care and reduce
costs. Self-administered testing by the patient following
instruction at the sleep laboratory by trained staff is the
preferred method for acquiring the necessary physiologic
data with such a device. The American Sleep Disorders
Association (ASDA) has classified diagnostic systems into
four categories based on the testing environment, technician
attendance, and number of parameters recorded [16]. Level
I is reserved for technician-attended in-laboratory PSG.
Portable monitoring ranges from level II (unattended, full
polysomnography) to level IV (single channel such as
simple pulse oximetry). ASDA level III is reserved for
devices that monitor airflow, chest/abdominal excursion,
heart/pulse rate, and oxyhemoglobin saturation.
The portable monitoring device investigated in this
study is a single-channel ASDA Level IV device that
monitors changes in nasal pressure (a surrogate measure
of airflow) with a nasal cannula, pressure transducer, and
recording unit that provides signal processing and data
analysis. The device monitors changes in nasal pressure
to detect respiratory events and calculate an index
representing the number of these events per hour of the
overnight recording. Since the device only requires
placement of a nasal cannula and securing the recording
unit to the patient's bed clothing, it should be well-suited
for self-administered testing. Furthermore, since the
device automatically calculates the outcome of the
overnight test, it requires minimal effort by the sleep
laboratory staff or physician to conduct the test other than
instructing the patient in its proper use. The aim of this
study was to validate the output from the single-channel
device against the standard for SDB detection, attended
polysomnography in a laboratory setting.
Materials and methods
Participants
A convenience sample of adult patients referred to the
Sleep Center of Greater Pittsburgh clinical sleep laboratory
with suspected OSA participated in this investigation.
Inclusion criteria included an age between 18 and 80 years,
ability to provide informed consent and follow instructions,
and medically stable status. Exclusion criteria were acute
respiratory failure, periodic limb movement index greater
than 10 events per hour on the night of the study,
supplemental oxygen therapy, presence of tracheostomy,
major nasal deformity (e.g., deviated septum), acute
sinusitis or otitis media, or unwillingness or inability to
tolerate a sleep study. Informed consent was obtained from
all participants after the protocol was approved by the
Institutional Review Board.
Protocol
All participants underwent standard in-laboratory overnight
polysomnography (PSG). Signals recorded included electro-
encephalogram (C4-A1, C3-A2, O2-A1, and O1-A2),
electro-oculogram, submental and bilateral tibial electro-
myogram, electrocardiogram, airflow (nasal–oral thermistor
and nasal pressure [PTAF2, Pro-Tech Services, Woodinville,
WA, USA]), chest and abdominal excursion (piezo bands),
oxyhemoglobin saturation, and body position. All PSG data
were collected and stored using the Sandman digital PSG
system (Nellcor Puritan Bennett (Melville) Ltd., Kanata, ON,
Canada). Nasal pressure was concurrently recorded on both
the PSG and the portable monitoring device (RUSleeping™
RTS, Respironics, Murrysville, PA, USA). This was accom-
plished using a single nasal cannula attached to the subject and
a Y-connector to split the cannula tubing to two pressure
transducers: one for the PSG and one within the portable
monitoring device.
PSGs were all scored manually by the same registered
technologist at the Sleep Center of Greater Pittsburgh, who
was blinded to the portable monitoring device data. Sleep
was staged according to standard criteria [17]. Arousals
were defined according to the American Sleep Disorders
Association (ASDA) guidelines [18]. Apneas and hypo-
pneas were scored according to the American Academy of
Sleep Medicine (AASM) guidelines for measurement in
clinical research [19]. An apnea–hypopnea index (AHI)
was then calculated based on the number of apneas plus
hypopneas per hour of sleep.
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The portable monitoring device included a small
recording unit to monitor the change in nasal pressure with
respiration using a nasal cannula. Power was provided for
the device with a single 1.5 V AAA battery. Prior to
beginning each overnight study with the device, the
technologist first verified that airflow was being detected
using the bar graph on the device display (six out of the 12
bars are indicated when no breathing is detected; then the
number of bars increases with inspiration and decreases
with exhalation). The technologist reset the internal counter
on the device to zero before lights out. The device then
continuously monitored the subject's respiration to detect
respiratory events (maximum recording time: 9 h). Respi-
ratory events were scored by the device when the peak-to-
peak nasal pressure waveform initially fell at least below
50% of the baseline value (mean peak-to-peak airflow of
eight breaths preceding initial breath of potential respiratory
event) and remained below at least 75% of the baseline
value for a minimum of 10 s. If the respiratory event
elapsed time counter reached 4 min, then the signal was
considered “not valid” for that period, the elapsed time
counter was automatically reset, the respiratory event was
discarded, and that hour of the recording was marked to
indicate that a “not valid” period occurred. The device
displayed the total elapsed hours of the recording and the
real-time respiratory event index (REI) on the liquid crystal
display (LCD). The REI represents the number of apneas
and hypopneas detected by the portable monitoring device
per hour of elapsed time for the recording. If a given hour
had three “not valid” periods (at least 12 min without valid
airflow), then that hour of the recording was discarded,
marked as “ERR” and did not count toward the respiratory
event index. At the conclusion of each overnight study, the
REI reported on the recording unit display was documented
by the technologist for future data analysis. The display was
also queried to determine the number of respiratory events
for each hour of the study and to determine if any hours
were marked as “ERR”.
Data analysis
Sleep studies were considered acceptable for data analysis
if none of the following rejection criteria occurred: (1) PSG
total sleep time (TST) less than 2 h, (2) portable monitoring
device elapsed time less than 2 h, or (3) poor quality PSG
recording (defined as a substantial portion of the PSG not
being interpretable for the scoring of sleep and respiratory
events). The PSG was considered the standard for identi-
fying and quantifying SDB. The portable monitoring device
REI was compared to the AHI calculated from the PSG
using the previously mentioned criteria.
The utility and accuracy of the portable monitoring
device REI in detecting SDB was based on summary data
and was evaluated in a number of ways. These included
evaluations of concordance using linear regression and
agreement using the method of Bland and Altman [20]. To
assess the detection of varying degrees of SDB severity, we
constructed receiver operating characteristic (ROC) curves
[21] (Systat Software, SigmaPlot 10.0) using PSG AHI
thresholds of 5, 15, and 30 corresponding to mild,
moderate, and severe SDB, respectively.
All results are given as means ± 1 standard deviation
except when standard error is indicated. The differences for
the Bland–Altman analyses are given as means (2 SD for
limits of agreement). Statistical significance was considered
to be present when p<0.05.
Results
We recruited and enrolled a total of 25 subjects with
suspected OSA, who met prospective eligibility require-
ments for participation in this investigation. This was not a
consecutive series of subjects, but a convenience sample of
willing participants who met enrollment criteria when staff
and beds were available to conduct the investigation. No
PSGs or portable device studies met our criteria for data
failure, and the results from all 25 enrolled subjects (16
female) are included in the data analysis. Five subjects had
1 h, one had 2 h, and one had 4 h marked as “ERR”
(representing hours with at least 12 min of “not valid”
airflow) by the portable device. Table 1 provides descrip-
tive data and the distribution of SDB severity (based on
PSG) for all participants. The PSG mean recording time
was 391.2±41.3 min and the PSG mean total sleep time
was 319.0±83.2.0 min. The portable monitoring device
Table 1 Descriptive data for all subjects and based on SDB severity using PSG AHI
N Gender Age (years) BMI (kg m−2)
All Subjects 25 9 M, 16 F 42.4±12.9 31.0±7.4
No SDB AHI <5 h−1 7 1 M, 6 F 27.7±6.1 26.6±4.3
Mild SDB (5≥AHI <15 h−1) 6 1 M, 5 F 41.1±6.9 30.0±7.0
Moderate SDB (15≥AHI
<30 h−1)
7 3 M, 4 F 52.5±10.9 33.4±6.7
Severe SDB (AHI≥30 h−1) 5 4 M, 1 F 50.8±8.0 37.4±8.6
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recorded a mean of 6.7±1.3 h with valid airflow per
subject. The mean PSG AHI was 20.6±26.8 events per
hour while the mean REI calculated by the portable
monitoring device was 18.1±11.5 events per hour. There
was a significant correlation between the PSG AHI and
portable monitoring device REI (R=0.73, p<0.0001,
Fig. 1a). Agreement was assessed using the Bland–Altman
plot as shown in Fig. 1b. There was good agreement across
a wide range of SDB severity except where the REI
underestimated the AHI by 87.7 events per hour in one
subject with an AHI of 133.5 events per hour.
We constructed ROC curves (see Figs. 2, 3 and 4) to
assess the sensitivity and specificity of the portable
monitoring device using a range of PSG AHI threshold
values (5, 15 and 30 events per hour) to differentiate normal
cases from those with SDB. The area under the curve
(AUC) was 0.94 (SE 0.05, p<0.001, 95% CI 0.84–1.0),
0.88 (SE 0.07, p<0.001, 95% CI 0.74–1.0), and 0.91 (SE
0.06, p<0.001, 95% CI 0.79–1.0), respectively. Table 2
provides the sensitivity, specificity, and corresponding
likelihood ratios for the marked REI cutoffs on Figs. 2, 3,
and 4.
Discussion
In this investigation, we assessed the diagnostic accuracy of
a simple portable device to detect sleep-related respiratory
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Fig. 2 ROC curve for discriminating subjects with SDB (PSG AHI≥5
events per hour) from those without SDB using the portable
monitoring device REI (solid line). The AUC is 0.94 (SE 0.05, p<
0.001, 95% CI 0.84–1.0). The ROC curve is constructed using
increasing cutoffs for the REI to detect SDB. Four of these cutoffs are
marked and represent (A: REI 4.3, B: REI 9.2, C: REI 11.9, and D:
REI 13.3) Definition of abbreviations: ROC receiver operating
characteristic, SDB sleep-disordered breathing, PSG polysomnogram,
AHI apnea–hypopnea index, REI respiratory event index, AUC area
under curve
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Fig. 1 In-laboratory comparisons are shown. a Scatter plot of PSG
AHI vs. Device REI. b Bland–Altman plot of PSG AHI vs. Device
REI. Agreement was good and the difference on the Bland–Altman
plot remained relatively constant for increasing severity of SDB
except for one subject with a PSG AHI of 133.5 events per hour
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(PSG AHI ≥ 15 events hr-1) 
Fig. 3 ROC curve for discriminating subjects with moderate–severe
SDB (PSG AHI≥15 events h−1) from those without moderate–severe
SDB using the portable monitoring device REI (solid line). The AUC
is 0.88 (SE 0.07, p<0.001, 95% CI 0.74–1.0). The ROC curve is
constructed using increasing cutoffs for the REI to detect SDB. Five of
these cutoffs are marked and represent (E: REI 11.9; F: REI 15.2; G:
REI 16.7; H: REI 20.6, and I: REI 35.1)
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events with concurrent PSG in the sleep laboratory in a
population with suspected SDB. This device monitors a
single channel (nasal pressure) to detect respiratory events
and continuously reports a real-time REI based on the
number of respiratory events per hour of recording time.
The portable device REI agreed with the degree of SDB
determined by the PSG AHI (see Fig. 1). The REI area
under the ROC curve ranged from 0.88 to 0.94 for all levels
of SDB (see Figs. 2–4). Technical failures (i.e. less than 2 h
of reliable data during the recording time) did not occur in
the study and hours with more than 12 min of “not valid”
airflow were uncommon. These data extend previous
findings for this portable monitoring device [22–24].
These data also suggest this portable device can be used
to increase the pretest odds for SDB (PSG AHI≥5 events
per hour) by 620% with a positive test (REI> 11.9 events
per hour) while reducing the posttest odds to 13% of the
pretest odds for a negative test (REI≤11.9 events per hour).
Thus, the device offers clinical utility as a simple method to
assess the presence of SDB (at any level) in high-risk
populations such as patients with diabetes, refractory
hypertension, and other cardiovascular disorders. The
device provides similar results to detect moderate-severe
SDB and may prove useful in clinical applications such as
screening patients prior to surgery or to assess efficacy of
mandibular advancement devices.
The portable device we investigated offers several
potential advantages over other portable monitoring sys-
tems. First, the device consists of only a small recording
unit that can be easily clipped onto the subject's bedclothes
and requires only a single sensor attachment (nasal cannula)
to acquire the necessary data. This makes the device well
suited for self-administered testing in an ambulatory
environment such as the home where numerous sensors
can impair the reliability for collecting data in remote
settings. Second, the device automatically calculates a real-
time REI without downloading data to a computer. This
reduces the sleep laboratory resources required to dispense
the devices, educate patients on proper use, and determine
the REI. Third, the disposable supplies needed to conduct a
study are limited to a single nasal cannula. This offers a
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(PSG AHI ≥ 30 events hr-1)
Fig. 4 ROC curve for discriminating subjects with severe SDB (PSG
AHI≥30 events per hour) from those without severe SDB using the
portable monitoring device REI (solid line). The AUC is 0.91 (SE
0.06, p<0.001, 95% CI 0.79–1.0). The ROC curve is constructed
using increasing cutoffs for the REI to detect SDB. Four of these
cutoffs are marked and represent (J: REI 7.6, K: REI 16.0, L: REI
22.6, and M: REI 28.4)
Table 2 Sensitivity, specificity, and likelihood ratios corresponding to REI cutoffs marked on the ROC curve figures
SDB severity Figure marker REI > Sensitivity 95% CI Specificity 95% CI LR+ LR−
PSG AHI≥5 A 4.3 1.0 0.81–1.0 0.29 0.04–0.71 1.4 0.00
B 9.2 0.94 0.73–1.0 0.57 0.18–0.90 2.2 0.10
C 11.9 0.89 0.65–0.99 0.86 0.42–1.0 6.2 0.13
D 13.3 0.83 0.59–0.96 1.00 0.59–1.0 ∞ 0.17
PSG AHI≥15 E 11.9 1.0 0.74–1.0 0.62 0.32–0.86 2.6 0.00
F 15.2 0.92 0.62–1.0 0.77 0.46–0.95 4.0 0.11
G 16.7 0.75 0.43–0.95 0.85 0.55–0.98 4.9 0.30
H 20.6 0.58 0.28–0.85 0.92 0.64–1.0 7.6 0.45
I 35.1 0.25 0.05–0.57 1.00 0.75–1.0 ∞ 0.75
PSG AHI≥30 J 7.6 1.0 0.66–1.0 0.50 0.25–0.75 2.0 0.00
K 16.0 0.89 0.52–1.0 0.75 0.48–0.93 3.6 0.15
L 22.6 0.78 0.40–0.97 0.94 0.70–1.0 12.4 0.23
M 28.4 0.67 0.30–0.93 1.00 0.79–1.0 ∞ 0.33
Abbreviations: ROC receiver operating characteristic, SDB sleep-disordered breathing, PSG polysomnogram, AHI apnea–hypopnea index, REI
respiratory event index, AUC area under curve, CI confidence interval, LR+ likelihood Ratio for a positive (+) test, LR likelihood ratio for a
negative (−) test.
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cost advantage over other systems, which require expensive
single patient use supplies to conduct a study.
Our investigation and the device also have a number of
limitations. First, the study was limited to a small number
of eligible participants who were willing to participate in a
research study at only one sleep center. The proportion of
females in our study was also high for a sleep lab
population. Thus, these results may not extend to other
populations. Second, the data were acquired on a single
night in a sleep laboratory and did not include an additional
night in an ambulatory environment such as the home.
However, comparisons on different nights and different
testing environments (lab vs. home) are not ideal. Third, the
device detects sleep disordered breathing with a single
nasal pressure channel, so some events may be difficult to
detect. Fourth, the raw nasal pressure data were not
available for review or for editing the scoring of events.
Thus, our data were automatically calculated by the
portable device and were unedited. Fifth, the portable
device cannot calculate an REI specific to body position
nor can it differentiate apneas from hypopneas or central
from obstructive apneas nor can it exclude respiratory
events during periods of irregular breathing patterns during
wake. These limitations may prove unsatisfactory in
determining a differential diagnosis in some patients.
In conclusion, this study indicates that the RUSleeping™
RTS portable monitoring device can accurately assess the
presence and severity of SDB compared to concurrent
polysomnography in the sleep laboratory, with a low failure
rate for single use and minimal technician time compared to
PSG. Due to the estimated prevalence of SDB in the general
population that can be substantially higher in high-risk
groups, access to timely diagnosis and treatment is important.
As sleep physicians and technologists become more familiar
with ambulatory monitoring technology, portable devices
will play a greater role in the management of this disorder. As
a field, we must evolve our sleep disorder programs to not
only focus on the next patient that walks through the clinic
door for evaluation, but also the leadership to manage sleep
disorders for all patients within our communities. For this to
become a reality, the future of sleep medicine will likely
include a more diverse diagnostic armamentarium consisting
of sleep laboratory-based polysomnography, limited channel
cardiopulmonary studies, AND even single-channel portable
monitoring in the home. Otherwise, it is just one-size-fits-all:
in-lab polysomnography to diagnose SDB and titrate CPAP.
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